about
Nutrition and Stroke PreventionGrapefruit juice-drug interactionsA comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes.Recent advances in pathogenesis, assessment, and treatment of atherosclerosisRecurrent stroke and patent foramen ovale: a systematic review and meta-analysisOvercoming Challenges With Statin TherapyRelationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive diseaseCarotid endarterectomy--an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyCombining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling studyBenefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial CollaboratorsEffects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individualsAnthropometric data for magnetic resonance imaging of the carotid bifurcation.Vitamin Intervention for Stroke Prevention (VISP) trial: rationale and design.Recent advances in preventing stroke recurrence.Vitamin B12, homocysteine and carotid plaque in the era of folic acid fortification of enriched cereal grain productsManagement of resistant hypertension in patients with carotid stenosis: high prevalence of renovascular hypertension.Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.One, two and three-dimensional ultrasound measurements of carotid atherosclerosis before and after cardiac rehabilitation: preliminary results of a randomized controlled trial.Increased prevalence of mitral valve prolapse in patients with migraine.Interaction of citrus juices with felodipine and nifedipine.Technology Insight: ultrasound measurement of carotid plaque--patient management, genetic research, and therapy evaluation.Treatment options for renovascular hypertension.Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial.Extremes of unexplained variation as a phenotype: an efficient approach for genome-wide association studies of cardiovascular diseaseRelationship of the metabolic syndrome to carotid ultrasound traits.Carotid ultrasound phenotypes in vulnerable populations3D ultrasound imaging of the carotid arteries.Premature atherosclerosis is associated with hypovitaminosis D and angiotensin-converting enzyme inhibitor non-use in lupus patients.Intestinal Microbiome and Atherosclerosis.Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see.Intensive management of risk factors for accelerated atherosclerosis: the role of multiple interventions.Mesna for treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial.Homocysteine-lowering therapy: a role in stroke prevention?Effect of renal impairment on atherosclerosis: only partially mediated by homocysteineAdding carotid total plaque area to the Framingham risk score improves cardiovascular risk classification.Role of renin-angiotensin system blockade in atherosclerotic renal artery stenosis and renovascular hypertension.Perspective on the efficacy analysis of the Vitamin Intervention for Stroke Prevention trial.Intensive risk factor control in stroke prevention.Polypill: for Pollyanna.Measurement of intima-media thickness vs. carotid plaque: uses in patient care, genetic research and evaluation of new therapies.
P50
Q22306365-39C3C2FD-77F4-4D71-B2C5-BD246153BE48Q24683430-A4328F42-0164-474C-9599-D406A091C7C8Q24812190-4DF63D29-D831-49B6-BB8A-E127FE5963E3Q26740304-BB91F619-F9CC-43D8-95AD-DDC3CD3C3185Q27003924-B3B84A74-9745-489E-9DDA-ECC217F13F5BQ28073319-226E597B-3ECE-4EFA-B320-2B5D5CB38555Q28165915-BD8500D5-EC7E-435B-80F1-A92E8D0DCE85Q28192186-8E3AABBA-6220-43CF-B85B-6019FEE6ADF3Q28222267-840E14D8-7EAA-4ECF-98DE-9310C456459CQ28288542-CFE26F84-C799-43CC-A0AE-D2755B0A3CACQ30833390-15787D27-B093-4443-AFDF-4CAAECB908B6Q30990261-97EB121B-7ECC-47B1-80EB-281CD6E44D23Q31927915-D8B842C7-EAF0-4A21-8D3E-4A54B6B5AE17Q33873364-65BE3E29-088D-4308-A4C9-E69FB0CEA0FBQ33940846-1FF09C44-66CF-4D8F-80B1-746F08545D3CQ33957239-B373B339-9F4B-42B9-937E-85C1270438F7Q34142959-C77A0889-82A5-4A6D-99F0-0EF4367A2CE0Q34493347-EFB03821-A4BA-44E1-9D6D-434C17F0AFDCQ34545519-0D02A6DD-DDDC-41E1-9CAC-9522DE484EECQ34567652-51A39C0E-89CD-42E7-8C3D-493D8803146EQ34576040-06EF6C21-5712-4057-BEFA-2EACAA7073A9Q34588690-589C8D5E-793E-442B-8ABC-826F934406EBQ34625239-0762535B-D040-412B-8338-C0EEBAA29EF6Q34885931-6E872E15-338A-4863-88C1-E357054E1B9DQ34945093-5B0F51BC-E150-446F-91E4-06EE6A2DE4ABQ35161439-3D46AC14-EC81-4C7B-9AEA-EBEB12A49D71Q35793910-B719B142-C976-46C3-A094-01A37B5AC750Q35881719-A6339196-D090-4B3F-806D-1D865E6AF89CQ36204352-B75F3A54-428A-4C83-B547-F6DDC05B5751Q36434865-5A6DD2F9-90AB-4ADB-BB43-04FF7353DAB9Q36705451-36553FCA-9992-4D1A-BCD7-A3414FB1A18CQ36736622-D4C7774E-8F30-43F6-9BBD-558B5C1EB90EQ36913508-8527C85D-45AC-4C39-A999-288558A65F47Q36926923-25A686B4-4995-4A03-8F3C-891236AC187EQ36958257-7ADD6820-0858-4671-822C-E74F92DD2AD6Q36965505-C722A381-335D-4B43-9F51-9A50689153E7Q36971867-FB58A33D-B971-4219-A6D2-ADE1AE2220DBQ37215333-4C3115AD-E204-40FC-8404-3CF473E8B1E7Q37244546-E7463B4E-295F-4126-B94A-6F29AAE1D21BQ37244574-412EEF98-C788-4AE4-949C-452FCD84C430
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
J. David Spence
@ast
J. David Spence
@en
J. David Spence
@es
J. David Spence
@nl
J. David Spence
@sl
type
label
J. David Spence
@ast
J. David Spence
@en
J. David Spence
@es
J. David Spence
@nl
J. David Spence
@sl
altLabel
David Spence spence jd, spence d, John David Spence
@en
prefLabel
J. David Spence
@ast
J. David Spence
@en
J. David Spence
@es
J. David Spence
@nl
J. David Spence
@sl
P1153
P244
P1053
K-6396-2013
P106
P1153
55826752200
56076126900
7201644534
P21
P214
110149841930602841294
P244
n2005088525
P31
P3829
P496
0000-0001-7478-1098
P569
1944-11-10T00:00:00Z
P734
P735
P7859
lccn-n2005088525